These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15977295)

  • 1. Group sequential clinical trials for longitudinal data with analyses using summary statistics.
    Kittelson JM; Sharples K; Emerson SS
    Stat Med; 2005 Aug; 24(16):2457-75. PubMed ID: 15977295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes.
    Galbraith S; Marschner IC
    Stat Med; 2003 Jun; 22(11):1787-805. PubMed ID: 12754715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of group sequential methods for binary longitudinal data.
    Spiessens B; Lesaffre E; Verbeke G
    Stat Med; 2003 Feb; 22(4):501-15. PubMed ID: 12590410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome.
    Hall SM; Delucchi KL; Velicer WF; Kahler CW; Ranger-Moore J; Hedeker D; Tsoh JY; Niaura R
    Nicotine Tob Res; 2001 Aug; 3(3):193-202. PubMed ID: 11506764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of longitudinal randomized clinical trials using item response models.
    Glas CA; Geerlings H; van de Laar MA; Taal E
    Contemp Clin Trials; 2009 Mar; 30(2):158-70. PubMed ID: 19146991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting analysis times in randomized clinical trials.
    Bagiella E; Heitjan DF
    Stat Med; 2001 Jul; 20(14):2055-63. PubMed ID: 11439420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential meta-analysis of past clinical trials to determine the use of a new trial.
    Bollen CW; Uiterwaal CS; van Vught AJ; van der Tweel I
    Epidemiology; 2006 Nov; 17(6):644-9. PubMed ID: 17028503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK; Lachin JM
    Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing complex group sequential survival trials.
    Lakatos E
    Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summarizing data through a piecewise linear growth curve model.
    Chandrasekaran V; Gopal G; Thomas A
    Stat Med; 2005 Apr; 24(8):1139-51. PubMed ID: 15568186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.